Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.

Saved in:
Bibliographic Details
Title: Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia.
Authors: Crotti, C.1, Zucchi, F.1, Alfieri, C.2,3, Caporali, R.1,2, Varenna, M.1 massimo.varenna@asst-pini-cto.it
Source: Osteoporosis International. Feb2023, Vol. 34 Issue 2, p423-424. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0937941X
DOI:10.1007/s00198-022-06618-1